BCL11B monoallelic deletions or missense mutations occurred across each of the major molecular subtypes of T-ALL, which suggested that BCL11B is a haploinsufficient tumor suppressor in human thymocyte transformation38. This evidence concerns the gene BCL11B and neoplasm.